Clinical Trial Update: The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer [NA]

View source ↗

Summary

A clinical trial investigating preoperative Lactobacillus reuteri with neoadjuvant immunotherapy for primary resectable hepatocellular carcinoma; currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immunotherapy (immunotherapy)
• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: HCC - Hepatocellular Carcinoma | NA | Status: NOT_YET_RECRUITING